SAM
DAWN

Smartleaf Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Smartleaf Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107 Hold
5
– – ﹤0.01% 3393
2025
Q4 		$46 Hold
5
– – ﹤0.01% 3437
2025
Q3 		$34 Hold
5
– – ﹤0.01% 2988
2025
Q2 		$32 Sell
5
-19
-79% -$131 ﹤0.01% 2707
2025
Q1 		$193 Buy
+24
New +$259 ﹤0.01% 2800
2024
Q3 		– Sell
-19
Closed -$262 – 2922
2024
Q2 		$262 Buy
+19
New +$278 ﹤0.01% 2644

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Smartleaf Asset Management's DAWN Position: Q1 2026 in Review

Smartleaf Asset Management held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 5 shares worth $107. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Smartleaf Asset Management first reported a position in DAWN in Q2 2024 and has held it in 6 quarters since. The position peaked at $262 in Q2 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Smartleaf Asset Management held 5 shares of Day One Biopharmaceuticals worth $107 as of Q1 2026.
  • Smartleaf Asset Management left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3393 holding.
  • Smartleaf Asset Management first reported a position in Day One Biopharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • Smartleaf Asset Management's Day One Biopharmaceuticals position peaked at $262 in Q2 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.